Randall Kaye, Senior VP, Chief Medical Officer at AVANIR PHARMACEUTICALS, INC. (AVNR), sold 3,349 shares at $2.10 ($7K) on 2009-09-15, disclosed to the SEC on 2009-09-15.
Open-market sale of $7k AVNR by Senior VP, Chief Medical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.21 | 1,349 | $3K | 41.5% |
| 2 | $2.10 | 2,000 | $4K | 58.5% |
| Total | $2.14 avg | 3,349 | $7K | 100% |
| Filing → |
| LBPH | SELL | 2024-08-13 | $1.2M | — | Filing → |
| LBPH | BUY | 2024-08-13 | $2K | — | Filing → |
| AXSM | BUY | 2015-12-24 | $9K | — | Filing → |